University of Stuttgart, Institute for Interfacial Engineering, Nobelstrasse 12, Stuttgart, Germany.
Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):300-11. doi: 10.1016/j.addr.2011.03.004. Epub 2011 Mar 17.
The main limitation in engineering in vitro tissues is the lack of a sufficient blood vessel system - the vascularization. In vivo almost all tissues are supplied by these endothelial cell coated tubular networks. Current strategies to create vascularized tissues are discussed in this review. The first strategy is based on the endothelial cells and their ability to form new vessels known as neoangiogenesis. Herein prevascularization techniques are compared to approaches in which biomolecules, such as growth factors, cytokines, peptides and proteins as well as cells are applied to generate new vessels. The second strategy is focused on scaffold-based techniques. Naturally-derived scaffolds, which contain vessels, are distinguished from synthetically manufactured matrices. Advantages and pitfalls of the approaches to create vascularized tissues in vitro are outlined and feasible future strategies are discussed.
工程化体外组织的主要限制因素是缺乏足够的血管系统——血管化。在体内,几乎所有的组织都是由这些内皮细胞包裹的管状网络供应的。本综述讨论了目前创建血管化组织的策略。第一种策略基于内皮细胞及其形成新血管的能力,即新生血管形成。在此,将预血管化技术与应用生物分子(如生长因子、细胞因子、肽和蛋白质)的方法进行了比较,以生成新血管。第二种策略侧重于基于支架的技术。含有血管的天然衍生支架与合成制造的基质有所区别。概述了体外构建血管化组织的方法的优缺点,并讨论了可行的未来策略。